Bidirectional Risk Observed for Inflammatory Bowel Disease, Depression
Increased risk also seen among unaffected siblings of patients with either depression or IBD
Home
Risk for Suicide Elevated in Patients With Cancer in the US
Standardized mortality ratio for suicide decreased from 2000 to 2016, but risk remains elevated, especially within first two years of diagnosis
Perception of E-Cigarettes as More Harmful Increased From 2019 to 2020
Between 2019 and 2020, there was an increase in the perception of electronic cigarettes as more harmful than cigarettes.
FDA Approves First Treatment for Eosinophilic Esophagitis
The U.S. FDA approved the monoclonal antibody Dupixent (dupilumab) to treat eosinophilic esophagitis patients 12 years and older.
Rifaximin Effective for Multiple Symptoms in Irritable Bowel Syndrome With Diarrhea
Researchers analyzed the efficacy of rifaximin for relieving IBS-D symptoms, specifically abdominal pain, bloating, and bowel movement urgency.
Early Return-to-Work Program Mitigates Clinician Staffing Shortages During COVID-19
Graham M. Snyder, MD, MS, provides further insight into a study that evaluated the effects of an early return-to-work program that reduced the quarantine period for clinicians who remained asymptomatic after exposure to COVID-19.
We Run Clinical Trials for Medications, Why Not for Apps?
The author comments on the current situation where behavioral modification smartphone apps do not undergo any oversight such as safety or efficacy studies, nor do they go through the Institutional Review Board to guide or evaluate ethics.
Risk for Shoulder Conditions Small After Vaccination in Deltoid Muscle
There is a small absolute risk for shoulder conditions after intramuscular vaccination administered in the deltoid muscle.
Emergency Mental Health Visits Increase After COVID-19 Surges
Findings show increases specifically for young adults and individual racial and ethnic minoritized subpopulations
PreHevbrio Now Available for Adult Hepatitis B Vaccination
The approval was based on data from two phase 3 studies, which compared the safety and immunogenicity of PreHevbrio to Engerix-B in adults.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in News
Loading... 
Loading...